Tags

Type your tag names separated by a space and hit enter

Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery.
Ann Thorac Surg. 2006 Mar; 81(3):815-9.AT

Abstract

BACKGROUND

Patients who undergo off-pump coronary artery bypass graft surgery (OPCAB) may be hypercoagulable with an increased risk of graft thrombosis due to the lack of platelet dysfunction that accompanies "on-pump" surgery. Clopidogrel may be indicated in these patients to prevent recurrent ischemic events. The purpose of this observational study was to determine the safety of early clopidogrel administration after OPCAB.

METHODS

Thirty-day follow-up of 364 consecutive OPCAB patients (January to June, 2002) was determined from a computerized database. One hundred ninety-three patients received clopidogrel 4 hours postoperatively if chest tube output was less than 100 cc/h for 4 hours, then daily for 4 weeks. Aspirin was administered preoperatively and postoperatively to all patients. Telephone follow-up was made 6 to 12 months after OPCAB.

RESULTS

None of the patients who received clopidogrel in the early postoperative period required reoperation for mediastinal hemorrhage. Mean chest tube drainage at 24 hours was 1,024 +/- 563 mL in patients who received clopidogrel and 942 +/- 501 mL in patients who did not receive clopidogrel. The total number of blood units transfused and the number of patients receiving blood transfusions were similar between groups. In-hospital mortality was 1.6% in patients who received clopidogrel and 3.5% in patients who did not receive clopidogrel. No group differences in mortality or adverse cardiac events were observed at 6 months. Gastrointestinal bleeding occurred in 2.2% clopidogrel patients versus 0.7% of patients who did not receive clopidogrel.

CONCLUSIONS

When administered according to our postoperative protocol, OPCAB patients can safely receive clopidogrel in the early postoperative period without increased risk for mediastinal hemorrhage.

Authors+Show Affiliations

Division of Cardiothoracic Surgery, Joseph B. Whitehead Department of Surgery, Emory Crawford Long Hospitals, Emory University School of Medicine, Atlanta, Georgia, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

16488678

Citation

Halkos, Michael E., et al. "Early Administration of Clopidogrel Is Safe After Off-pump Coronary Artery Bypass Surgery." The Annals of Thoracic Surgery, vol. 81, no. 3, 2006, pp. 815-9.
Halkos ME, Cooper WA, Petersen R, et al. Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery. Ann Thorac Surg. 2006;81(3):815-9.
Halkos, M. E., Cooper, W. A., Petersen, R., Puskas, J. D., Lattouf, O. M., Craver, J. M., & Guyton, R. A. (2006). Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery. The Annals of Thoracic Surgery, 81(3), 815-9.
Halkos ME, et al. Early Administration of Clopidogrel Is Safe After Off-pump Coronary Artery Bypass Surgery. Ann Thorac Surg. 2006;81(3):815-9. PubMed PMID: 16488678.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery. AU - Halkos,Michael E, AU - Cooper,William A, AU - Petersen,Rebecca, AU - Puskas,John D, AU - Lattouf,Omar M, AU - Craver,Joseph M, AU - Guyton,Robert A, PY - 2005/03/20/received PY - 2005/08/28/revised PY - 2005/08/29/accepted PY - 2006/2/21/pubmed PY - 2006/9/9/medline PY - 2006/2/21/entrez SP - 815 EP - 9 JF - The Annals of thoracic surgery JO - Ann Thorac Surg VL - 81 IS - 3 N2 - BACKGROUND: Patients who undergo off-pump coronary artery bypass graft surgery (OPCAB) may be hypercoagulable with an increased risk of graft thrombosis due to the lack of platelet dysfunction that accompanies "on-pump" surgery. Clopidogrel may be indicated in these patients to prevent recurrent ischemic events. The purpose of this observational study was to determine the safety of early clopidogrel administration after OPCAB. METHODS: Thirty-day follow-up of 364 consecutive OPCAB patients (January to June, 2002) was determined from a computerized database. One hundred ninety-three patients received clopidogrel 4 hours postoperatively if chest tube output was less than 100 cc/h for 4 hours, then daily for 4 weeks. Aspirin was administered preoperatively and postoperatively to all patients. Telephone follow-up was made 6 to 12 months after OPCAB. RESULTS: None of the patients who received clopidogrel in the early postoperative period required reoperation for mediastinal hemorrhage. Mean chest tube drainage at 24 hours was 1,024 +/- 563 mL in patients who received clopidogrel and 942 +/- 501 mL in patients who did not receive clopidogrel. The total number of blood units transfused and the number of patients receiving blood transfusions were similar between groups. In-hospital mortality was 1.6% in patients who received clopidogrel and 3.5% in patients who did not receive clopidogrel. No group differences in mortality or adverse cardiac events were observed at 6 months. Gastrointestinal bleeding occurred in 2.2% clopidogrel patients versus 0.7% of patients who did not receive clopidogrel. CONCLUSIONS: When administered according to our postoperative protocol, OPCAB patients can safely receive clopidogrel in the early postoperative period without increased risk for mediastinal hemorrhage. SN - 1552-6259 UR - https://www.unboundmedicine.com/medline/citation/16488678/Early_administration_of_clopidogrel_is_safe_after_off_pump_coronary_artery_bypass_surgery_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0003-4975(05)01576-6 DB - PRIME DP - Unbound Medicine ER -